---
report: Citation Audit
section: 1
run_date: 2026-07-24
pass: 1 (self-reviewed)
verdict: PASS (2 items flagged, non-blocking)
---

# Citation Audit — Section 1 (Executive Summary), v2 draft

**Tooling note.** Performed in-context by the top-level session in the `evidence-citation-agent` role
(Stage 13.9), per `bp-orchestrator.md`'s documented runtime constraint (no `Agent` tool available). Not
an independently-invoked Pass 2 — this is Pass 1/self-reviewed, per
`vault/Architecture/Business_Plan_Generation_Pipeline.md`'s two-pass verification rule.

**Scope and method, specific to Section 1.** Per `exec-summary-agent.md`'s own procedure, Section 1
introduces no new evidence — its only permitted sources are the thirteen already-drafted sections
(`Section_02` through `Section_14`) themselves, not the raw vault. Accordingly, this audit does not
re-verify Sections 2-14's own underlying `(DocID, page N)` citations a second time (each of those
sections carries its own Pass-1 citation audit already on file, e.g.
`Citation_Audit_Section_02_v2.md`, `Citation_Audit_Section_03_v2.md`, `Citation_Audit_Section_06_v2.md`,
`Citation_Audit_Section_07_v2.md`, `Citation_Audit_Section_08_v2.md`, `Citation_Audit_Section_10_v2.md`,
`Citation_Audit_Section_11_v2.md`, `Citation_Audit_Section_14_v2.md`) — it verifies instead that **every
claim in Section 1 accurately restates a claim that genuinely exists in its cited source section**, with
no drift, no invented figure, and no number appearing here that Sections 2-14 do not themselves already
carry. This is the correct audit question for a synthesis section: fidelity to source sections, not
re-derivation from Facts.

## Walk-through, claim by claim

| # | Claim in Section 1 | Cited source | Verified against source section | Result |
|---|---|---|---|---|
| 1 | DFM listing, "IPO priced December 2024"; FY2025 GMV USD9.5bn (+28% cFX), revenue USD3.9bn, Adj. EBITDA USD615mn (6.5%), 7.5mn active customers | `Problem_Charter.md` | Matches `Problem_Charter.md` "Strategic problem" paragraph verbatim in substance | Pass |
| 2 | "From a multi-vertical food-delivery platform to the region's Everyday App" | TLB-020 p.16; Section 2 §2.1 | Matches Section 2 §2.1's own quotation verbatim | Pass |
| 3 | USD175mn = ~120mn Everyday App + ~55mn Food-leadership, internally funded | `Investment_Portfolio_Register.md`; TLB-020 p.16 | Matches Section 2, 9, and 14's identical figures | Pass |
| 4 | Q1 2026 Adj. EBITDA margin 4.8% (vs. 6.3% y/y; vs. 6.0% Q4 2025) | `Problem_Charter.md`; Section 10 §10.3 (`FIN-01`) | Matches Section 10 §10.3's own dual-comparator framing (both the Problem Charter's y/y comparator and the Section's own q/q comparator are stated, not merged) | Pass |
| 5 | Non-high-value M1 retention -4% y/y, UAE/Kuwait/Qatar | TLB-019 p.9; Section 3 | Matches Section 3 §3.3 and Section 10 §10.2 (`MKT-01`) exactly, including the market-comparison scope (not Group-wide) | Pass |
| 6 | Grocery/retail penetration 1-3% of USD104-150bn+ addressable category | Section 3 §3.1 | Matches Section 3's own top-down sizing, including its explicit note that the two TAM figures (104bn/150bn+) are presented unreconciled, not blended — Section 1 does not force-reconcile them either | Pass |
| 7 | No disclosed internal capital-allocation stage-gate mechanism | `Capital Allocation and Investment Governance.md`; Section 8 §8.4 | Matches Section 8's 7S "Systems: Not ready" finding and Section 10's `ORG-01` | Pass |
| 8 | Governing hypothesis (evidence-ranked, stage-gated framework raises realized GMV/EBITDA/CLV contribution) | Section 2 §2.3 | Matches Section 2 §2.3 verbatim in substance (compressed, not misquoted) | Pass |
| 9 | Five ranked options (`OPT-001`-`005`) and recommended funding sequence (near-term `OPT-002`/`OPT-003`; continue-at-pace `OPT-001`/`OPT-005`; longer-horizon `OPT-004`) | `DEC-009`; Section 9 §9.2, §9.6; Section 12 | Matches Section 9 §9.2's "Recommended funding sequence" and Section 12's Three Horizons tiering identically — no option was reassigned to a different tier | Pass |
| 10 | FY2026 guidance base case: GMV +11-14% cFX, Revenue +14-17% cFX, Adj. EBITDA 4.4-4.8% of GMV, FCF 3.2-3.6% of GMV | Section 9 §9.3; TLB-020; TLB-014 | Matches Section 9 §9.3's table exactly, Group-level, base case only — no upside/downside figure is presented as the headline here, consistent with `DEC-008` | Pass |
| 11 | No disclosed ROI/payback/return figure for either bucket | Section 9 §9.1, §9.4; `Investment_Relationship_Map.md` | Matches Section 9's explicit statement and Section 4 §4.3's identical finding | Pass |
| 12 | Human/team approval required before capital moves | `Problem_Charter.md`; Section 11 §11.3; `Investment_Portfolio_Register.md` "Owner" | Matches Section 11 §11.3's "Governance structure 3" and the Portfolio Register's Owner section, both quoted accurately | Pass |
| 13 | Top three risks `FIN-01`, `MKT-01`, `ORG-01` (High×High quadrant) | Section 10 §10.6 | Matches Section 10's probability-impact matrix exactly — these are the only three risks in the High×High cell | Pass |
| 14 | No disclosed country/GCC/non-GCC/initiative-level allocation breakdown | `Problem_Charter.md`; `Capital Allocation and Investment Governance.md` | Matches Section 2 §2.2 "problem 3" and Section 9's own statement | Pass |
| 15 | No churn rate/baseline anywhere in the corpus | Section 13, "Churn — the Single Biggest Customer-Side Gap" | Matches Section 13 verbatim in substance | Pass |
| 16 | AI product = internal decision-support system, not customer-facing; target market = talabat's own capital-allocation process; USP = evidence-traceable framework vs. undisclosed status quo | Section 2 §2.4-2.5; Section 4 §4.1; Section 5 §5.1-5.2 | Matches all three sections' consistent framing (internal capability, embedded not sold) | Pass |
| 17 | Business model: fully internally funded, no incremental capital requested | Section 9 §9.6 | Matches Section 9 §9.6 verbatim in substance | Pass |
| 18 | DEC-009 allocation-range placement restriction (no OPT-level dollar figure appears in Section 1) | `DEC-009`; Section 14 §14.3 | Verified by inspection: Section 1 contains **zero** dollar figures for any individual `OPT-001`-`005` option anywhere in its text — the restriction is honored by omission, not by a labeled exception, which is the correct treatment for a section that has no legitimate reason to reproduce the sensitivity exhibit | Pass |

## Items flagged (non-blocking — do not fail this section, but must not be silently dropped)

1. **DFM listing-date discrepancy across the plan, inherited (not introduced) by Section 1.**
   `Problem_Charter.md` states "IPO priced December 2024"; Sections 2, 5, and 14 each state "Dubai
   Financial Market listing, November 2024" (citing TLB-025 and TLB-001, pages 11-12). Section 1 cites
   `Problem_Charter.md`'s December 2024 figure, which is internally consistent with its own source, but
   the plan as a whole has not reconciled this discrepancy anywhere. Per the citation-audit skill's own
   rule ("a citation to a note with an unresolved internal discrepancy is not automatically a failure...
   but the audit must note it"), this is noted here and is **not** a Section 1 citation failure — it is a
   whole-plan Financial/Problem Consistency item for Part C (Stage 14/16) to resolve, not something
   Section 1 can or should resolve unilaterally by picking a side.
2. **No new numeric claim originates in Section 1.** Confirmed by design (per `exec-summary-agent.md`'s
   procedure) and by this walk-through — every figure in Section 1 traces to an already-cited figure in
   Sections 2-14, none is newly computed or newly sourced here. This is stated as a positive audit finding
   for Section 1 specifically, not a gap.

## Geography-tag spot-check (per the citation-audit skill's rule against unlabeled geography transfer)

Every geography-bearing claim reproduced in Section 1 (rows 1, 4, 5, 6, 9-11, 13-15 above) carries the
same geography scope as its source section — no Group-level figure was widened, no market-comparison
figure (row 5, UAE/Kuwait/Qatar) was presented as Group-wide, and no figure was narrowed to Egypt-specific
where its source was Group-level. Zero geography-transfer failures found.

## Verdict

**PASS.** 18/18 claims resolve correctly to their cited source section with no drift; zero unresolved
numeric claims; zero unlabeled geography transfers; two items flagged as noted above, both non-blocking
and both explicitly carried forward rather than silently resolved.

## See also
[[Section_01_Executive_Summary]] · `.claude/skills/citation-audit/SKILL.md` ·
`vault/Architecture/Business_Plan_Generation_Pipeline.md`
